Category & Conditions: Cancer
Study Phase : 2
Medicine: DAURISMO TABLETS(GLASDEGIB)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: EUCRISA™(CRISABOROLE)
PrintDownloadCategory & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 2
Medicine: FRAGMIN®(DALTEPARIN SODIUM INJECTION)
PrintDownloadCategory & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: LYRICA® AND LYRICA®CR(PREGABALIN) AND (PREGABALIN EXTENDED RELEASE TABLETS)
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: PREVNAR 13(PNEUMOCOCCAL 13-VALENT CONJUGATE VACCINE [DIPHTHERIA CRM197 PROTEIN])
PrintDownloadCategory & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Bavencio (avelumab)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1/2
Medicine: Lorbrena (lorlatinib)
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: marstacimab (PF-06741086)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: PF-06480605
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: PF-06482077
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: Talzenna (talazoparib)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: tanezumab
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: tanezumab
PrintDownloadCategory & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: tanezumab
PrintDownloadCategory & Conditions: Cancer
Study Phase : 2
Medicine: Xtandi (enzalutamide)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: PF-06650833
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: PF-06700841
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: Domagrozumab (PF-06252616)
PrintDownloadCategory & Conditions: Neurological Diseases and Conditions
Study Phase : 2
Medicine: PF-06649751
PrintDownload